AVXL logo

Anavex Life Sciences (AVXL) Cash From Investing

Annual CFI

N/A

September 30, 2024

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

AVXL Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$0.00
AVXL annual cash flow from investing activities is currently at an all-time high

3-Year Low

-
AVXL annual cash flow from investing activities 3-year low is unknown

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
AVXL previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
AVXL next annual earnings announcement has not yet been scheduled

OtherAVXLcash flowmetrics:

Annual CFF

$11.97 M
AVXL annual cash flow from financing activities is $11.97 million

Annual CFO

-$30.81 M
AVXL annual cash flow from operations is -$30.81 million

Annual FCF

-$30.81 M
AVXL annual free cash flow is -$30.81 million

Annual CAPEX

-
AVXL annual capital expenditures value is unknown

Quarterly CFI

N/A

December 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

AVXL Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$104.60 K
AVXL quarterly cash flow from investing activities is currently at an all-time high

3-Year Low

-
AVXL quarterly cash flow from investing activities 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
AVXL previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
AVXL next earnings announcement is scheduled for May 9, 2025

OtherAVXLcash flowmetrics:

Quarterly CFF

$708.00 K
AVXL quarterly cash flow from financing activities is $708.00 thousand

Quarterly CFO

-$12.12 M
AVXL quarterly cash flow from operations is -$12.12 million

Quarterly FCF

-$12.12 M
AVXL quarterly free cash flow is -$12.12 million

Quarterly CAPEX

-
AVXL quarterly capital expenditures value is unknown

TTM CFI

N/A

December 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

AVXL TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$0.00
AVXL TTM cash flow from investing activities is currently at an all-time high

3-Year Low

-
AVXL TTM cash flow from investing activities 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
AVXL previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
AVXL next earnings announcement is scheduled for May 9, 2025

OtherAVXLcash flowmetrics:

TTM CFF

$12.62 M
AVXL TTM cash flow from financing activities is $12.62 million

TTM CFO

-$35.61 M
AVXL TTM cash flow from operations is -$35.61 million

TTM FCF

-$35.61 M
AVXL TTM free cash flow is -$35.61 million

TTM CAPEX

-
AVXL TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AVXL Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

AVXL Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

Anavex Life Sciences Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2014
-$3000.00(<-9900.0%)
-$700.00(<-9900.0%)
-$3000.00(+30.4%)
Jun 2014
-
$0.00(0.0%)
-$2300.00(0.0%)
Mar 2014
-
$0.00(-100.0%)
-$2300.00(0.0%)
Dec 2013
-
-$2300.00(<-9900.0%)
-$2300.00(<-9900.0%)
Sep 2013
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2012
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2012
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Jun 2012
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2012
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2011
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2011
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Jun 2011
-
$0.00(0.0%)
-$3300.00(0.0%)
Mar 2011
-
$0.00(0.0%)
-$3300.00(0.0%)
Dec 2010
-
$0.00(-100.0%)
-$3300.00(0.0%)
Sep 2010
-$3300.00
-$3300.00(<-9900.0%)
-$3300.00(<-9900.0%)
Jun 2010
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2010
-
$0.00(0.0%)
$0.00(0.0%)
DateAnnualQuarterlyTTM
Dec 2009
-
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2009
-$1200.00(+9.1%)
-
-
Sep 2008
-$1100.00(<-9900.0%)
$104.60 K(-488.8%)
-$1100.00(-99.0%)
Jun 2008
-
-$26.90 K(-65.9%)
-$105.70 K(+34.1%)
Mar 2008
-
-$78.80 K(<-9900.0%)
-$78.80 K(<-9900.0%)
Dec 2007
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2007
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Jun 2007
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2007
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2006
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2006
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Jun 2006
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2006
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2005
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2005
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Jun 2005
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2005
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2004
-
$0.00
$0.00
Sep 2004
$0.00
-
-

FAQ

  • What is the all time high annual CFI for Anavex Life Sciences?
  • What is the all time high quarterly CFI for Anavex Life Sciences?
  • What is the all time high TTM CFI for Anavex Life Sciences?

What is the all time high annual CFI for Anavex Life Sciences?

Anavex Life Sciences all-time high annual cash flow from investing activities is $0.00

What is the all time high quarterly CFI for Anavex Life Sciences?

Anavex Life Sciences all-time high quarterly cash flow from investing activities is $104.60 K

What is the all time high TTM CFI for Anavex Life Sciences?

Anavex Life Sciences all-time high TTM cash flow from investing activities is $0.00